Stockscreener 앱 받기
5.57
3.13%
-0.18
시간 외 거래:
5.68
0.11
+1.97%
전일 마감가:
$5.75
열려 있는:
$5.75
하루 거래량:
425.37K
Relative Volume:
0.79
시가총액:
$1.74B
수익:
$391.87M
순이익/손실:
$-441.45M
주가수익비율:
-3.0108
EPS:
-1.85
순현금흐름:
$-301.21M
1주 성능:
+1.83%
1개월 성능:
-0.54%
6개월 성능:
-43.39%
1년 성능:
-52.23%
1일 변동 폭
$5.40
$5.78
1주일 범위
$5.23
$5.85
52주 변동 폭
$4.32
$13.70
Alvotech Stock (ALVO) Company Profile
ALVO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
5.57 | 1.79B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Underweight |
| 2025-11-04 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-10-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-09-23 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-02-14 | 개시 | UBS | Buy |
| 2024-01-29 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-09-21 | 개시 | Barclays | Equal Weight |
| 2022-09-07 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-09-06 | 다운그레이드 | Citigroup | Buy → Sell |
| 2022-07-26 | 개시 | Citigroup | Buy |
모두보기
Alvotech 주식(ALVO)의 최신 뉴스
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
How Investors Are Reacting To Alvotech (ALVO) EU Approval Of AVT03 Denosumab Biosimilar - Sahm
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Defic - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AlvotechALVO - PR Newswire
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman - PR Newswire
Barclays Initiates Coverage of Alvotech (ALVO) with Underweight Recommendation - Nasdaq
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged ... - Bakersfield.com
ALVO Investor News: If You Have Suffered Losses in Alvotech - GlobeNewswire
Alvotech (NASDAQ:ALVO) Shares Gap DownHere's Why - MarketBeat
Alvotech (ALVO) Receives Underweight Rating from Barclays | ALVO Stock News - GuruFocus
Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - The Malaysian Reserve
Alvotech initiated with an Underweight at Barclays - TipRanks
Barclays Downgrades Alvotech(ALVO.US) to Sell Rating, Cuts Target Price to $5 - 富途牛牛
Certain Ordinary Shares of Alvotech are subject to a Lock-Up Agreement Ending on 8-DEC-2025. - marketscreener.com
Certain Swedish Depository Receipts of Alvotech are subject to a Lock-Up Agreement Ending on 8-DEC-2025. - marketscreener.com
What analysts say about Alvotech Z45 stockVolume Profile Analysis & Free Discover Dynamic Stocks - earlytimes.in
With Alvotech Stock Surging, Have You Considered The Downside? - Trefis
Alvotech Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Retail Surge: What technical signals suggest for BRT Apartments Corp stockTrade Risk Report & High Return Stock Watch Alerts - BỘ NỘI VỤ
Alvotech (NASDAQ:ALVO) Stock Price Up 6.3%Here's What Happened - MarketBeat
Alvotech (NasdaqGM:ALVO): Assessing Valuation After European Approval of Denosumab Biosimilar AVT03 - simplywall.st
How Alvotech Z45 stock correlates with oil marketsQuarterly Investment Review & Daily Profit Maximizing Tips - BỘ NỘI VỤ
Alvotech (ICSE:ALVO) Price Target Decreased by 17.29% to 1,165.86 - Nasdaq
ROSEN, LEADING INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - marketscreener.com
Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Alvotech (ALVO) - ACCESS Newswire
Would You Still Hold Alvotech Stock If It Fell 30%? - Trefis
Oaktree Capital Management LP Trims Position in Alvotech $ALVO - MarketBeat
Does Alvotech (Z45) stock trade below intrinsic valueQuarterly Portfolio Review & Entry Point Confirmation Signals - Newser
Will Alvotech (Z45) stock hit analyst forecasts2025 EndofYear Setup & Safe Entry Zone Tips - Newser
Alvotech Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Why Alvotech (Z45) stock remains stableWeekly Trade Report & Capital Efficient Trading Techniques - Newser
Alvotech (ALVO): A Bull Case Theory - Finviz
Will Alvotech (Z45) stock beat Nasdaq index returnsJuly 2025 Price Swings & Capital Efficient Trade Techniques - Newser
Is Alvotech Equity Warrant stock a safe haven assetJuly 2025 Earnings & Reliable Volume Spike Alerts - Newser
Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation – ALVO - The AI Journal
ALVO ALERT: Levi & Korsinsky Investigates Alvotech for Possible Securities Fraud Violations - ACCESS Newswire
What momentum indicators show for Alvotech stockWeekly Trade Analysis & Verified Momentum Stock Alerts - Newser
Alvotech (NASDAQ:ALVO) Reaches New 12-Month LowWhat's Next? - MarketBeat
Morgan Stanley Maintains Alvotech(ALVO.US) With Buy Rating, Cuts Target Price to $10 - 富途牛牛
What technical patterns form on Alvotech (Z45) stock chartsPortfolio Return Report & Smart Money Movement Alerts - Newser
Will Alvotech (Z45) stock rise with strong economyJuly 2025 Levels & Technical Entry and Exit Tips - Newser
Alvotech stock hits 52-week low at 4.69 USD By Investing.com - Investing.com Nigeria
Alvotech stock hits 52-week low at 4.69 USD - Investing.com
Alvotech, Advanz Pharma secure European approval for Gobivaz, Simponi biosimilar - MSN
How Alvotech (Z45) stock trades under stagflation2025 Retail Activity & Long-Term Safe Investment Plans - Newser
Why Alvotech (Z45) stock appeals to dividend investors2025 Price Momentum & Short-Term Swing Trade Alerts - Newser
European Commission Approves Denosumab Biosimilars for Alvotech, STADA, Dr. Reddy’s & Teva - Pearce IP
The SPC "Waiver Regulation" means what it says: Regeneron v Alvotech - Mishcon de Reya LLP
Bronstein, Gewirtz & Grossman, LLC Encourages Alvotech (ALVO) Sto - The National Law Review
What analysts say about Alvotech Equity Warrant stockMarket Correction Analysis & Affordable Portfolio Strategies - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Encourages Alvotech (ALVO) Sha - The National Law Review
Alvotech (ALVO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.48%
0.09%
자본화:
|
볼륨(24시간):